TMEM33 deletion potentiates anti-tumor CD8+ T cell immunity.

Jackson MT., Zhao T., Milotay G., Pedroza-Pacheco I., Cai Y., Willis C., Phyu SM., Beernaert B., Kwon JT., Estephan H., Almeida VP., Aggelakopoulou M., Panetti S., Zierhut C., Elliott T., Adamopoulou E., Rehwinkel J., Sim MJ., Grover A., Gabrilovich DI., Fairfax BP., Honoré E., Withers DR., Christianson JC., Parkes EE.

DOI

10.64898/2026.01.01.697288

Type

Preprint

Publication Date

2026-01-02T00:00:00+00:00

Keywords

T cell, TMEM33, Tpex, cancer immunity, endoplasmic reticulum

Permalink More information Close